Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Lavertu

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
The Laryngoscope|December 1, 2016
Contemporary management of carotid blowout syndrome utilizing endovascular techniquesNauman F Manzoor, Rod P Rezaee, Abhishek Ray, et al.
Thyroid : Official Journal of the American Thyroid Association|November 2, 2012
Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroidPanayiotis Savvides, Govardhanan Nagaiah, Pierre Lavertu, et al.
The Annals of Otology, Rhinology, and Laryngology|May 13, 2021
Outpatient Parotidectomy, a Safety and Financial ReviewMaxwell Scher, Claudia I Cabrera, Yida Cai, et al.
American Journal of Otolaryngology|November 14, 2016
Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancerCameron C Wick, Rod P Rezaee, Tammy Wang, et al.
Head & Neck|September 11, 2003
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?Scott A McHam, David J Adelstein, Lisa A Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapyDavid J Adelstein, Jerrold P Saxton, Pierre Lavertu, et al.
Head & Neck|June 24, 2014
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neckMin Yao, Nicholas Galanopoulos, Pierre Lavertu, et al.
Frontiers in Oncology|April 5, 2021
Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot StudyMichael Kharouta, Chad Zender, Tarun Podder, et al.
Head & Neck|February 27, 2016
Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinomaMin Yao, Charles Woods, Pierre Lavertu, et al.
American Journal of Otolaryngology|May 24, 2022
The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literatureBrooke A Quinton, Claudia I Cabrera, Akina Tamaki, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The Laryngoscope|December 1, 2016
Contemporary management of carotid blowout syndrome utilizing endovascular techniquesNauman F Manzoor, Rod P Rezaee, Abhishek Ray, et al.
Thyroid : Official Journal of the American Thyroid Association|November 2, 2012
Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroidPanayiotis Savvides, Govardhanan Nagaiah, Pierre Lavertu, et al.
The Annals of Otology, Rhinology, and Laryngology|May 13, 2021
Outpatient Parotidectomy, a Safety and Financial ReviewMaxwell Scher, Claudia I Cabrera, Yida Cai, et al.
American Journal of Otolaryngology|November 14, 2016
Use of concurrent chemoradiation in advanced staged (T4) laryngeal cancerCameron C Wick, Rod P Rezaee, Tammy Wang, et al.
Head & Neck|September 11, 2003
Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?Scott A McHam, David J Adelstein, Lisa A Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapyDavid J Adelstein, Jerrold P Saxton, Pierre Lavertu, et al.
Head & Neck|June 24, 2014
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neckMin Yao, Nicholas Galanopoulos, Pierre Lavertu, et al.
Frontiers in Oncology|April 5, 2021
Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot StudyMichael Kharouta, Chad Zender, Tarun Podder, et al.
Head & Neck|February 27, 2016
Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinomaMin Yao, Charles Woods, Pierre Lavertu, et al.
American Journal of Otolaryngology|May 24, 2022
The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literatureBrooke A Quinton, Claudia I Cabrera, Akina Tamaki, et al.
Pageof 6